No Data
No Data
Looking Into Recursion Pharmaceuticals's Recent Short Interest
Trending Industry Today: Serve Robotics Leads Gains In NVIDIA Portfolio Stocks
Recursion Pharmaceuticals, Inc. (RXRX): Among the Worst ARK Stocks According to Short Sellers
Morgan Stanley Maintains Recursion Pharmaceuticals(RXRX.US) With Hold Rating, Maintains Target Price $10
Needham Maintains Recursion Pharmaceuticals(RXRX.US) With Buy Rating, Cuts Target Price to $11
Cathie Wood's ARK Sells CareDx, Buys Recursion Pharmaceuticals Stock
No Data
No Data